Moderna Just Crushed Estimates While Everyone Was Looking the Other Way
Moderna (NASDAQ: MRNA | MRNA Price Prediction) reported fourth-quarter results Friday morning that beat Wall Street’s muted expectations, delivering revenue of $678 million against estimates of $663 million and a loss of $2.11 per…



















